1. Home
  2. OLOX vs NVNO Comparison

OLOX vs NVNO Comparison

Compare OLOX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olenox Industries Inc. Common Stock

OLOX

Olenox Industries Inc. Common Stock

N/A

Current Price

$0.93

Market Cap

6.1M

ML Signal

N/A

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$10.30

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLOX
NVNO
Founded
2007
1987
Country
United States
United States
Employees
N/A
37
Industry
RETAIL: Building Materials
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
7.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OLOX
NVNO
Price
$0.93
$10.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5M
13.3K
Earning Date
03-31-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,628.82
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$0.30
52 Week High
$2.19
$12.85

Technical Indicators

Market Signals
Indicator
OLOX
NVNO
Relative Strength Index (RSI) 43.06 47.65
Support Level $0.82 $9.76
Resistance Level $1.15 $12.69
Average True Range (ATR) 0.12 0.92
MACD -0.02 -0.25
Stochastic Oscillator 4.51 20.24

Price Performance

Historical Comparison
OLOX
NVNO

About OLOX Olenox Industries Inc. Common Stock

Olenox Industries Inc is an industrial holding company focused on acquiring, operating, and scaling businesses that provide engineered solutions across industrial, energy, and infrastructure markets. Through its subsidiaries, it delivers high-quality modular and containerized systems designed for rapid deployment and long-term performance.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: